> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Extends Comment Period on LASIK Labeling Guide
- URL: https://www.fdaweb.com/fda-extends-comment-period-on-lasik-labeling-guide/
- Published: 2022-10-12T12:00:00.000Z
- Updated: 2026-09-14T18:02:55.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152947

*Federal Register* notice: FDA has extended the comment period for a draft guidance entitled “Laser-Assisted In Situ Keratomileusis (LASIK) Lasers — Patient Labeling Recommendations.” Electronic and written comments on the draft guidance can now be submitted until 11/25\. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-10-11/pdf/2022-21971.pdf?ref=fdaweb.com).